Fatih Semerci

Title: Fatih Semerci: Innovator in Neurogenesis

Introduction

Fatih Semerci is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of neurogenesis through his innovative research and patent work. His expertise lies in developing small-molecule modulators that target the orphan nuclear receptor TLX.

Latest Patents

Fatih Semerci holds 1 patent for his invention titled "Small-molecule modulators of the orphan nuclear receptor TLX." This patent discloses small molecules that act through the ligand binding domain of nuclear receptor TLX (NR2E1). The invention aims to promote neurogenesis and treat disorders associated with nuclear receptor TLX, including neurological disorders such as Alzheimer's disease. The patent also provides compounds according to a specific formula and includes pharmaceutically acceptable salts or isomers thereof.

Career Highlights

Fatih Semerci is affiliated with the Baylor College of Medicine, where he conducts his research and development work. His role at this esteemed institution allows him to collaborate with other leading scientists and contribute to advancements in medical science.

Collaborations

Some of his notable coworkers include Prasanna Kandel and Damian Winston Young. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Fatih Semerci's work in developing small-molecule modulators for neurogenesis represents a significant advancement in treating neurological disorders. His contributions to science and medicine continue to pave the way for future innovations.